INRANGE-study: The impact of hybrid closed-loop insulin delivery on glycemic control and patient-reported outcomes in people living with type 1 diabetes: a multicenter real-world observational study in Belgium.
SURPASS-6: A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition
of Tirzepatide Once Weekly versus Insulin Lispro (U100) Three Times Daily in Participants
with Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) with or without
Metformin